Supplier profile
NOVARTIS FARMACEUTICA, S.A.
Every public-sector award we hold for this supplier, across Spain, from 3 Nov 2008 to 8 Oct 2026.
Awards won
1,163
all time
Attributed value
€1.5bn
209 shared, unvalued
Buyers
311
public bodies
Active
2008–2026
first to latest award
Awards by year
Who they win from
| Buyer | Awards | Value |
|---|---|---|
| Dirección Gerencia del Complejo Hospitalario Universitario de Canarias | 96 | €35.5m |
| Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín | 95 | €19.6m |
| Dirección Gerencia del Complejo Hospitalario Universitario Insular Materno Infantil | 68 | €18.6m |
| Dirección Gerente del Hospital Universitario Nuestra Señora de Candelaria | 58 | €18.8m |
| Servicio Madrileno de Salud, Hospital Universitario La Paz | 25 | €23.8m |
| Gerencia de Servicio Sanitarios de Fuerteventura | 21 | €3.9m |
| Osakidetza | 20 | €40.1m |
| Inspección General de Sanidad de la Defensa | 19 | €2.2m |
| Dirección General de Planificación Económica | 17 | €42.1m |
| Consorci Sanitari Integral | 16 | €1.7m |
What they win
Awards
Showing 526–550 of 1,163 awards we hold
- Suministro de Medicamentos de Uso Humano Tipo II, basado en Acuerdo Marco, expediente: 23/S/20/SU/DG/N/AM12. ↗Gerencia de Servicio Sanitarios de Fuerteventura€280kawarded 31 Mar 2022
- Spain-Vitoria-Gasteiz: Pharmaceutical products ↗Dirección General - Osakidetza€1.3mawarded 30 Mar 2022
- Suministro medicamentos principios activos bexaroteno, eribulina, lenvatinib, ribociclib, erenumab, midostaurina, encorafenib, binimetinib, reslizumab y fremanezumab ↗Servicio Murciano de Salud - Junta de Compras€1.5mawarded 29 Mar 2022
- Spain-Móstoles: Antineoplastic agents ↗CONSEJERIA DE SANIDAD DE LA COMUNIDAD DE MADRID.-SERVICIO MADRILEÑO DE SALUD.-HOSPITAL UNIVERSITARIO DE MOSTOLESshared awardawarded 29 Mar 2022
- Spain-Santa Cruz de Tenerife: Various medicinal products ↗Dirección Gerente del Hospital Universitario Nuestra Señora de Candelaria€424kawarded 28 Mar 2022
- Spain-Alcorcón: Pharmaceutical products ↗Hospital Universitario Fundación Alcorcón€2.4mawarded 18 Mar 2022
- Spain-Madrid: Pharmaceutical products ↗Servicio Madrileño de la Salud, Hospital Universitario Ramón y Cajal€829kawarded 18 Mar 2022
- Spain-Madrid: Pharmaceutical products ↗Servicio Madrileño de Salud - Hospital Central de la Cruz Roja "San José y Santa Adela"shared awardawarded 15 Mar 2022
- Suministro del medicamento TISAGENLECLEUCEL (kYMRIAH), con acuerdo de riesgo compartido, exclusivo de la firma NOVARTIS FARMACÉUTICA, S.A., con destino al Hospital Royo Villanova, adscrito al Sector Sanitario Zaragoza I, para el tratamiento de una paciente.
Procedimiento Negociado sin Publicidad por Exclusividad. Art. 168.A.2 ↗Gerencia Sector Sanitario de Zaragoza 1€320kawarded 18 Feb 2022
- Suministro medicamento Amovig 140 mg y Amovig 70 mg(principio activo Erenumab 140 mg pluma s.c. 1 ml y Erenumab 70 mg pluma s.c. 1 ml) con destino el Hospital Universitario Nuestra Señora de Candelaria ↗Dirección Gerente del Hospital Universitario Nuestra Señora de Candelaria€424kawarded 18 Feb 2022
- Spain-Madrid: Pharmaceutical products ↗Servicio Madrileno de Salud, Hospital Universitario La Pazshared awardawarded 16 Feb 2022
- Contrato basado en el acuerdo marco para el Suministro de medicamentos de uso humano II ↗Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín€233kawarded 14 Feb 2022
- Contrato basado en el acuerdo marco para el suministro de medicamentos de uso humano II ↗Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín€409kawarded 14 Feb 2022
- Spain-Madrid: Pharmaceutical products ↗HOSPITAL CLINICO SAN CARLOS DE MADRID€966kawarded 14 Feb 2022
- Spain-Madrid: Pharmaceutical products ↗HOSPITAL CLINICO SAN CARLOS DE MADRID€1.4mawarded 14 Feb 2022
- Spain-Barcelona: Pharmaceutical products ↗Institut Català de la Salut-Hospital Universitari Vall d'Hebron€5.5mawarded 11 Feb 2022
- PNSP 40/2021 adquisicion del principio activo secukinumab, deferasirox, ruxolitinib, ribociclib, ranibizumab, trametinib, eltrombopag, dabrafenib, pazopanib, everolimus y omalizumab (novartis farmaceutica, s.a.) ↗Gerencia del Area de Atención Integrada de Guadalajara€566kawarded 10 Feb 2022
- Suministro de medicamentos de uso humano tipo II (exclusivos), con destino al Servicio de Farmacia del Hospital Universitario Ntra. Sra. de Candelaria, derivado del Acuerdo Marco 23/S/20/SU/DG/N/AM12, suscrito en el ámbito del Servicio Canario de la Salud. ↗Dirección Gerente del Hospital Universitario Nuestra Señora de Candelaria€3.7mawarded 10 Feb 2022
- Spain-L'Hospitalet de Llobregat: Pharmaceutical products ↗Instituto Catalán de Oncologiashared awardawarded 9 Feb 2022
- Spain-Madrid: Pharmaceutical products ↗HOSPITAL CLINICO SAN CARLOS DE MADRID€1.9mawarded 4 Feb 2022
- Spain-Madrid: Pharmaceutical products ↗Servicio Madrileno de Salud, Hospital Universitario La Paz€1.5mawarded 4 Feb 2022
- Spain-Getafe: Various medicinal products ↗Hospital Universitario de Getafe€326kawarded 1 Feb 2022
- Spain-Palma: Pharmaceutical products ↗Servicio de Salud de las Illes Balears€7.1mawarded 31 Jan 2022
- contrato basado en el acuerdo marco para el suministro de medicamentos de uso humano II ↗Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín€707kawarded 24 Jan 2022
- contrato basado en el acuerdo marco para el suministro de medicamentos de uso humano II ↗Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín€309kawarded 24 Jan 2022
Possibly the same organisation
These entries differ from this one only by legal form or a bracketed qualifier, so they may be the same organisation — or a different registered company of the same name. They are kept apart on purpose: the figures on each page are per legal entity and are never combined.
Bidding against them?
Get new tenders in their space in a daily digest, scored against your own capability — plus the full notice behind each of these awards, with the documents and contacts it published.
Start 7-day free trialHow this profile is built
Awards are collected from official public procurement notices and deduplicated so one procurement counts once. Supplier names are grouped across their published spellings: case and punctuation are ignored, and “Ltd” is treated as optional because buyers routinely leave it off. Everything else that marks a different organisation is kept — an LLP, a plc, a CIC and a Teoranta are separate businesses from a Ltd of the same name, as are a parent and a named subsidiary, and none of them are merged here. Where another entry differs from this one only by legal form or a bracketed qualifier it is listed above as possibly the same organisation — a hint for the reader, never a merge: figures are per legal entity and never combined. Value is attributed only where the notice is explicit: the supplier's own itemised amount, or the whole value where they were the sole named supplier. Awards naming several suppliers without a published split are counted and marked shared, never valued, and a framework ceiling is never treated as money any one appointed supplier won. Sterling and euro are never added together. The linked source notice is authoritative.
Company pages are for organisations. If this page profiles you as an individual — a sole trader or an individual contractor — you can ask for it to be withheld: see how.